Stuart Rich

33.3k total citations · 9 hit papers
183 papers, 23.1k citations indexed

About

Stuart Rich is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Stuart Rich has authored 183 papers receiving a total of 23.1k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Pulmonary and Respiratory Medicine, 108 papers in Cardiology and Cardiovascular Medicine and 24 papers in Surgery. Recurrent topics in Stuart Rich's work include Pulmonary Hypertension Research and Treatments (137 papers), Cardiovascular Function and Risk Factors (40 papers) and Cardiovascular Issues in Pregnancy (40 papers). Stuart Rich is often cited by papers focused on Pulmonary Hypertension Research and Treatments (137 papers), Cardiovascular Function and Risk Factors (40 papers) and Cardiovascular Issues in Pregnancy (40 papers). Stuart Rich collaborates with scholars based in United States, Canada and United Kingdom. Stuart Rich's co-authors include Vallerie V. McLaughlin, Bruce H. Brundage, Elizabeth Kaufmann, Robyn J. Barst, P. S. Levy, Stephen L. Archer, Lewis J. Rubin, Mardi Gomberg‐Maitland, Alicia C. Shillington and Gérald Simonneau and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Stuart Rich

179 papers receiving 22.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival in Patients with Primary Pulmonary Hypertension

1991 2.6k citations Gilbert E. D’Alonzo, Robyn J. Barst et al. Annals of Internal Medicine profile →
A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 2.0k citations Robyn J. Barst, Lewis J. Rubin et al. profile →
Primary Pulmonary Hypertension

1987 1.5k citations Stuart Rich et al. Annals of Internal Medicine profile →
Clinical classification of pulmonary hypertension

2004 1.3k citations Gérald Simonneau, Nazzareno Galiè et al. Journal of the American College of Cardiology profile →
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension

1992 1.1k citations Stuart Rich, Elizabeth Kaufmann et al. profile →
Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial

2002 1.1k citations Gérald Simonneau, Robyn J. Barst et al. American Journal of Respiratory and Critical Care Medicine profile →
Survival in Primary Pulmonary Hypertension

2002 902 citations Vallerie V. McLaughlin, Stuart Rich et al. Circulation profile →
Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension

1996 813 citations Yola Moride, Stuart Rich et al. profile →
Pulmonary Arterial Hypertension

2013 378 citations Michael D. McGoon, Raymond L. Benza et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Stuart Rich

Since Specialization

Citations

This map shows the geographic impact of Stuart Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Rich more than expected).

Fields of papers citing papers by Stuart Rich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Rich. The network helps show where Stuart Rich may publish in the future.

Co-authorship network of co-authors of Stuart Rich

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Rich. A scholar is included among the top collaborators of Stuart Rich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Rich. Stuart Rich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Venous Tone and Stressed Blood Volume in Heart Failure 2022 ·Journal of the American College of Cardiology ·Marat Fudim, David M. Kaye, Barry A. Borlaug, Sanjiv J. Shah, Stuart Rich, Navin K. Kapur, Maria Rosa Costanzo, Michael I. Brener, Kenji Sunagawa, Daniel Burkhoff	51
2	Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study 2021 ·Pulmonary Circulation ·Sophia Emmons‐Bell, Catherine O. Johnson, (unknown), Paul A. Corris, Peter J. Leary, Stuart Rich, Magdi H. Yacoub, Gregory A. Roth	33
3	Changes in Stressed Blood Volume with Levosimendan in Pulmonary Hypertension from Heart Failure with Preserved Ejection Fraction: Insights Regarding Mechanism of Action From the HELP Trial 2021 ·Journal of Cardiac Failure ·Michael I. Brener, Nadira Hamid, Kenji Sunagawa, Barry A. Borlaug, Sanjiv J. Shah, Stuart Rich, Daniel Burkhoff	11
4	Survival in Patients with Primary Pulmonary Hypertension 2020 ·Annals of Internal Medicine ·Gilbert E. D’Alonzo, Robyn J. Barst, Stephen M. Ayres, Edward H. Bergofsky, Bruce H. Brundage, Katherine M. Detre, Alfred P. Fishman, Roberta M. Goldring, (unknown), (unknown), Paul S. Levy, Giuseppe G. Pietra, Lynne Reid, John Τ. Reeves, Stuart Rich, Carol E. Vreim, George W. Williams, Margaret Wu	3
5	Novel shunt modification with an adjustable stent‐embedded “fenestrated” septal occluder in a patient with pulmonary hypertension 2019 ·Catheterization and Cardiovascular Interventions ·(unknown), David Wax, Stuart Rich, (unknown)	1
6	Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension 2016 ·American Journal of Respiratory and Critical Care Medicine ·Anna R. Hemnes, Min Zhao, James West, John H. Newman, Stuart Rich, Stephen L. Archer, Ivan M. Robbins, Timothy S. Blackwell, Joy D. Cogan, James E. Loyd, Zhongming Zhao, Christa Gaskill, Christopher S. Jetter, Jonathan A. Kropski, Susan M. Majka, Eric D. Austin	55
7	Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension 2014 ·Circulation ·Anna R. Hemnes, Aaron W. Trammell, Stephen L. Archer, Stuart Rich, Chang Yu, Hui Nian, Niki Penner, (unknown), Lisa Wheeler, Ivan M. Robbins, Eric D. Austin, John H. Newman, James West	59
8	Pulmonary Arterial Hypertension breakdown → 2013 ·Journal of the American College of Cardiology ·Michael D. McGoon, Raymond L. Benza, Pilar Escribano Subías, Xin Jiang, Dave P. Miller, Andrew J. Peacock, Joanna Pepke‐Żaba, Tomás Pulido, Stuart Rich, Stephan Rosenkranz, Samy Suissa, Marc Humbert	378
9	Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation 2009 ·European Respiratory Journal ·Thenappan Thenappan, Sanjiv J. Shah, Stuart Rich, Lian Tian, Stephen L. Archer, Mardi Gomberg‐Maitland	360
10	Relationship of BMPR2 Mutations to Vasoreactivity in Pulmonary Arterial Hypertension 2006 ·Circulation ·C. Gregory Elliott, Eric W. Glissmeyer, (unknown), John F. Carlquist, Jason T. McKinney, Stuart Rich, Michael D. McGoon, Mary Beth Scholand, Miryoung Kim, Robert L. Jensen, (unknown), Kenneth Ward	110
11	Efficacy and Safety of Treprostinil: An Epoprostenol Analog for Primary Pulmonary Hypertension 2003 ·Journal of Cardiovascular Pharmacology ·Vallerie V. McLaughlin, Seán Gaine, Robyn J. Barst, Ronald J. Oudiz, Robert C. Bourge, Adaani Frost, Ivan M. Robbins, Victor F. Tapson, Michael D. McGoon, David B. Badesch, (unknown), R.F. Roscigno, (unknown), Carl Arneson, Lewis J. Rubin, Stuart Rich	176
12	Sitaxsentan in Pulmonary Arterial Hypertension 2003 ·CHEST Journal ·Robyn J. Barst, Stuart Rich, Allison Widlitz, Evelyn M. Horn, Vallerie V. McLaughlin, (unknown)	1
13	Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial breakdown → 2002 ·American Journal of Respiratory and Critical Care Medicine ·Gérald Simonneau, Robyn J. Barst, Nazzareno Galiè, Robert Naeije, Stuart Rich, Robert C. Bourge, Anne Keogh, Ronald J. Oudiz, Adaani Frost, (unknown), James W. Crow, Lewis J. Rubin	1052
14	Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension 2002 ·CHEST Journal ·Robyn J. Barst, Stuart Rich, Allison Widlitz, Evelyn M. Horn, Vallerie V. McLaughlin, (unknown)	171
15	Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension 1998 ·Pneumologie ·(unknown), (unknown), (unknown), Stuart Rich	21
16	Appetite-suppressant drugs and the risk of primary pulmonary hypertension 1997 ·Pneumologie ·Lucien Abenhaim, Yola Moride, F Brénot, Stuart Rich, (unknown), Xavier Kurz, T W Higenbottam, Caroline Oakley, E.F.M. Wouters, Michel Aubier, G. Simonneau, Bernard Bégaud	7
17	Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels 1995 ·Journal of the American College of Cardiology ·Mark Nootens, Elizabeth Kaufmann, Thomas S. Rector, Cynthia Toher, Dianne Judd, Gary S. Francis, Stuart Rich	256
18	Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension 1993 ·Journal of the American College of Cardiology ·(unknown), Bruce J. Schrader, Elizabeth Kaufmann, Robert E. Vestal, Stuart Rich	38
19	Comparison of the effects of adenosine and nifedipine in pulmonary hypertension 1992 ·Journal of the American College of Cardiology ·Bruce J. Schrader, (unknown), (unknown), Robert E. Vestal, Stuart Rich	79
20	Pulmonary hypertension: A cellular basis for understanding the pathophysiology and treatment 1989 ·Journal of the American College of Cardiology ·Stuart Rich, Bruce H. Brundage	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact